In recent years, intense research has been directed towards understanding molecular mechanisms involved in viral pathogenesis. It is now known that many viruses manipulate host defense mechanisms to prevent apoptosis in order to maximize viral replication. Towards the end of their replication cycle, certain viruses direct the synthesis of proteins that induce apoptosis or cell lysis thereby facilitating viral release from the cell. The present review summarizes the current understanding of interactions between viral proteins and the host cell death machinery.
Introduction
Virologists have long believed that viruses produce their cytotoxic and lethal effects by disrupting the cellular transcriptional or translational machinery or by altering membrane integrity of the host cell (Hardwick, 1997) . Although such processes do account for the adverse effects produced by certain viruses towards host cells, there is a growing recognition that many viruses kill cells by triggering apoptosis. Conversely, it is also known that viruses may exploit apoptotic pathways to achieve viral latency or to preserve the viability of the host cell, thereby prolonging the duration of viral replication (Rudin and Thompson, 1997) . In this regard, many viruses induce apoptosis only during the late stages of infection . In fostering cellular integrity, certain viruses find a favorable long-term niche in the host. Persistence allows viruses the opportunity to`optimize' replication, while controlling the release of viral progeny and the nature of immune perturbation.
Many of the morphological and biochemical changes that occur during virus-induced apoptosis in cell culture systems do not differ greatly from those observed using other unrelated pro-apoptotic stimuli. Apoptosis is characterized by cell shrinkage, chromatin condensation, DNA fragmentation and the formation of apoptotic bodies. Caspases (cysteinyl aspartate proteinases) are believed to play a significant role in the proteolytic cleavage of certain structural and functional proteins which may contribute to the manifestation of the apoptotic phenotype (Nicholson and Thornberry, 1997) . Membrane-enclosed apoptotic bodies are recognized and engulfed by adjacent, normally non-phagocytic cells as well as by phagocytic cells (Hardwick, 1997) . However, in certain tissues, the extent of apoptosis may be so profound that the number of healthy, uninfected cells capable of phagocytosis is insufficient to handle the burden of apoptotic cells. The accumulation of apoptotic vesicles bearing viral antigens, accompanied by the gradual disintegration and lysis of non-phagocytosed apoptotic bodies may be major factors in the evocation of inflammatory responses associated with many viral infections. Thus, unlike most non-infectious forms of apoptosis or programmed cell death, virus-induced apoptosis can elicit a non-specific inflammatory response as apoptosis and necrosis merge.
In the present mini-review, we will focus on interactions of viral proteins with specific host proteins that determine the fate of the virus and the infected cell, primarily based on events which serve to promote or inhibit an apoptotic response. We will assess strategies utilized by viruses to target and modulate the activity of regulatory proteins in the death pathway.
Viral proteins that inhibit apoptosis
Prior to the formation of specific anti-viral cellular or humoral immune responses, the induction of apoptosis may represent an early protective host cell response, eliminating virus-infected cells and limiting viral reproduction (Rudin and Thompson, 1997) . Alternatively, many viruses have evolved exquisite strategies to inhibit Cell Death and Differentiation (1998) 5, 653 ± 659 apoptosis (Table 1 ) providing avenues to enhance viral replication or establish persistence in select cells (Thomson, 1995) .
Interaction of specific viral proteins with components of the apoptotic pathway provides a basis for influencing the dynamic balance between life and death in cells, elimination or persistence of virus and the development of transient or sustained immunological and inflammatory responses. Molluscum contagiosum virus, equine herpesvirus 2, bovine herpesvirus 4, human herpesvirus 8 and herpesvirus saimiri contain FLICE-inhibitory proteins (FLIPs) which possess FLICE (caspase-8)-homologous sequences that interact with the adapter Fas-associated death domain protein (FADD) Hu et al, 1997; Senkevich et al, 1997; Thome et al, 1997) . This FLIP-FADD interaction serves to block caspase-8 activation and downstream events induced by the binding of Fas or TNF receptor to their respective ligands (Thome et al, 1997) . Expression of the cowpox serpin CrmA (cytokine response modifier A) has been shown to block caspase-8-mediated activation of downstream caspases including caspase-1 and caspase-3 (Srinivasula et al, 1996; Zhou et al, 1997) . The IAPs (inhibitor of apoptosis proteins) constitute a family of proteins found in baculoviruses which, when expressed can block apoptosis induced by viral infection or by caspase-1 (Yuan, 1997) . Although the antiapoptotic mechanism of viral IAPs is not fully understood, evidence has shown that IAPs may interact with TNF receptor associated factor-2 (TRAF-2) (Uren et al, 1996) . Furthermore, cellular IAPs are direct inhibitors of caspases and have been shown to bind directly to caspase-3 and -7 (Devereaux et al, 1997) .
Several viruses have evolved strategies to block the action of tumor suppressor genes such as p53 and the (Cuff and Ruby, 1996; Teodoro and Branton, 1997) . Such regulation of host DNA synthesis is exemplified by human adenoviruses (Li et al, 1997) , Simian virus 40 (Conzen et al, 1997) , human papillomaviruses (HPV) (Brown et al, 1997) and hepatitis B viruses (HBV) (Chirillo et al, 1997) . Certain viral genomes encode proteins with highly conserved domains characteristic of Bcl-2-related proteins. These Bcl-2 homologous (BH) regions may dimerize or interact with other proteins within the Bcl-2 family. The Epstein Barr virus BHRF1 and adenovirus E1B-19 kDa proteins are Bcl-2 homologues (Chiou et al, 1994; Henderson et al, 1993) . E1B-19 kDa has been shown to interact with and inhibit apoptosis induced by pro-apoptotic Bcl-2 family members such as Bax, Bak and Bik (Rao et al, 1997) . Sequence analysis has identified a novel viral anti-apoptotic Bcl-2 homologue, designated KSbcl-2, from human herpesvirus 8 (HHV8) or Kaposi sarcoma-associated herpesvirus that does not homo-dimerize or hetero-dimerize with other Bcl-2 proteins . KSbcl-2, may have evolved to evade the pro-apoptotic negative regulatory effects of host Bax and Bak proteins .
Viral proteins that induce apoptosis
The mechanisms by which viral proteins interact with host cellular proteins to produce apoptotic cell death are not as well-defined as those for viral proteins that inhibit apoptosis. However, viruses are capable of utilizing several diverse mechanisms to promote apoptosis (Table 2) . Certain viruses induce apoptosis through the direct action of specific viral proteins (Rao et al, 1992) , while other viruses may indirectly induce cell death by blocking host transcriptional or translational mechanisms (Barco and Carrasco, 1995) .
Although specific viral proteins are implicated in the induction of apoptotic cell death, others have been shown to promote necrotic cell death. Adenoviruses are wellknown for their ability to cause viral protein-induced necrosis. Adenoviruses typically infect quiescent cells which do not support viral replication (Hardwick, 1997) . The adenovirus E1A protein drives the infected cells into Sphase, promoting viral DNA replication, but also inadvertently induces apoptosis (Rao et al, 1992; Wold, 1993) . (Ubol et al, 1994) However, the E1B 19K protein functions to prevent premature E1A-induced apoptosis, thereby permitting the progression of viral replication (White et al, 1991) . To facilitate viral release, the adenovirus death protein (ADP or E3 11.6K) induces cell lysis late in the replication cycle, allowing for the release of accumulated viral progeny since apoptosis was blocked by the E1B 19K protein (Tollefson et al, 1996a) . Cell lysis during the late phase of adenovirus infection is associated with expression of high levels of ADP in contrast to the low levels observed during the early infectious period (Tollefson et al, 1992) . Interestingly, cells lysed by adenovirus do not exhibit an apoptotic morphology (Tollefson et al, 1996b) and such programmed necrosis may be unique to these lytic viruses.
Other viral strategies exist for inducing apoptosis. The African swine fever virus encodes a protein homologue (5EL/ A238L) of the human inhibitor kB (IkB) protein which binds to nuclear factor-kB (NF-kB) and blocks translocation of NF-kB to the nucleus in response to NF-kB activating stimuli (Neilan et al, 1997) . Through such a mechanism the virus may prevent NF-kB-mediated transcription and upregulation of proinflammatory cytokine production which would serve to thwart viral spread (Powell et al, 1996) . Furthermore, 5EL may promote apoptosis, since NF-kB activation is also responsible for the transcription of antiapoptotic genes (Chu et al, 1997) . The baculovirus protein, EI-1, a transactivator of baculovirus gene expression induces apoptosis by an undefined mechanism (Prikhod'ko and Miller, 1996) . The chicken anemia virus encodes a nuclear binding protein, apoptin, which induces p53-independent apoptosis that is not regulated by Bcl-2 (Danen-Van Oorschot et al, 1997; Zhuang et al, 1995b) . Interestingly, apoptin induces apoptosis in malignant but not in normal cells although the explanation for this dichotomy is not understood (Danen-Van Oorschot et al, 1997) .
Apoptosis is a contributing feature in the chronic liver disease caused by hepatitis B virus (HBV). The HBV protein, pX, is a multi-functional protein which influences cell growth and p53-dependent cell death (Chirillo et al, 1997; Haviv et al, 1996) . Further, pX sensitizes otherwise TNF-resistant cells to apoptosis (Su and Schneider, 1997) . However, the mechanism of pX-mediated TNF sensitization remains undefined.
Clinically significant virus-induced T-lymphocyte apoptosis is observed in association with human immunodeficiency virus-1 (HIV-1) infection. However, the mechanisms of T cell death following HIV infection are controversial. It has been demonstrated that CD4+ and CD8+ T lymphocytes of HIV-infected individuals may be primed to undergo apoptosis in response to Fas stimulation, suggesting that Fas signaling may be important in T lymphocyte death in these patients (Katsikis et al, 1995) . The HIV transcription factor Tat may upregulate T cell Fas ligand expression, thereby contributing to the apoptotic death of Fasexpressing neighboring immune cells (Westendorp et al, 1995) . Together, HIV-1 Tat and the CD4 ligand gp120 may Figure 1 Points of viral protein interaction with host apoptosis-regulatory proteins. Cellular proteins are denoted which interact with viral proteins to either promote (A) or inhibit (I) apoptosis. Several host apoptotic proteins can be either up or downregulated, depending on the virus and the specific viral protein interaction, to produce either a pro-apoptotic or anti-apoptotic effect. Most likely, the state of the virus, the state of the host cell and the stage of infection also determine the probability of apoptosis Viral regulators of cell death DJ Granville et al augment Fas-mediated, activation-induced T cell apoptosis leading to T cell depletion (Brenneman et al, 1988; Westendorp et al, 1995) . However, tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL), a member of the TNF/nerve growth factor ligand family, is also capable of triggering activation-induced T cell death following HIV infection (Katsikis et al, 1997) . The reovirus s1 protein is responsible for viral binding to an uncharacterized receptor on the surface of target cells which subsequently trigger an apoptotic response (Tyler et al, 1995) . Other viruses including the parvovirus (Morey et al, 1993) , Sindbis virus (Ubol et al, 1994) and poliovirus (Tolskaya et al, 1995) also induce host cell apoptosis. The mechanisms by which these viruses induce host cell apoptosis are not established.
Conclusion
Apoptosis is a key host defense mechanism for the elimination of virus-infected cells and to impede the spread of virus. The acquisition of one or more anti-apoptotic genes by different viruses supports the existence of an antagonistic relationship between host and virus. Conversely, other viruses harness the apoptotic pathway to further viral infectivity and pathogenesis . Specific interactions between viral and host proteins may be key determinants maintaining cell survival or triggering cell death. With the explosive growth in research in this area, there exists great potential for the development of novel therapeutics to intercede in virally-mediated disease.
